Dr. Goy on Novel Therapies at the JTCC Conference

Andre Goy, MD, MS
Published Online: Tuesday, October 11, 2011
Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses how novel treatment options have revolutionized treatment for patients with non-small cell lung cancer, a disease that used to be considered “beyond surgery.”

Novel therapies, new characterizations of tumors, and a more personalized approach to treating these tumors will be discussed at the upcoming New Frontiers In The Management of Solid and Liquid Tumors conference at John Theurer Cancer Center at Hackensack University Medical Center, November 3-4, 2011.

Online CME Activities
Free CME from PER
Advances in the Treatment of Metastatic Colorectal Cancer
Renal Cell Carcinoma: Recent Advances, New Questions
Community Practice Connections™: Working Group to Advance the Treatment of Triple-Negative Breast Cancer: Examining the Evidence and Looking to the Future
Community Practice Connections™: 10th Annual New York Lung Cancer Symposium®
More Reading
$auto_registration$